SECURITIES AND EXCHANGE COMMISSION
Washington,
D.C. 20549
FORM 8-K
Current
Report
Pursuant
to Section 13 or 15(d) of
the
Securities Exchange Act of 1934
Date
of Report (Date of earliest event reported): July 29, 2010
VSE
CORPORATION
(Exact
Name of Registrant as Specified in its Charter)
DELAWARE
(State
or Other Jurisdiction of Incorporation or Organization)
0-3676 |
|
54-0649263 |
(Commission File Number) |
|
(I.R.S. Identification Number) |
2550 Huntington Avenue |
||
Alexandria, Virginia |
22303-1499 |
|
(Address of Principal Executive Offices) |
(Zip Code) |
Registrant's Telephone Number, Including Area Code: (703) 960-4600
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
[ ] Written
communications pursuant to Rule 425 under the Securities Act (17 CFR
230.425)
[ ] Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
240.14a-12)
[ ] Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR
240.14d-2(b))
[ ] Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR
240.13e-4(c))
VSE CORPORATION
Item 2.02. | Results of Operations and Financial Condition |
On July 29, 2010, VSE Corporation issued a press release announcing its financial results for the three- month period ended June 30, 2010. A copy of the press release is being furnished as Exhibit 99.1 to this Form 8-K and is hereby incorporated by reference.
Item 9.01. | Financial Statements and Exhibits |
(d) | Exhibits | ||
Exhibit |
|||
99.1 | Press Release dated July 29, 2010 entitled, "VSE Reports Financial Results for Second Quarter 2010" |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
VSE CORPORATION | ||
(Registrant) |
||
Date: July 29, 2010 |
/s/ T. R. Loftus |
|
T. R. Loftus |
||
Executive Vice President and Chief Financial Officer |